期刊文献+

Fas/FasL与皮肤肿瘤的相关性研究进展 被引量:2

Research Development of Relationship between Fas/FasL and Skin Cancer
下载PDF
导出
摘要 Fas/FasL均是细胞表面受体。Fas与FasL结合后可以导致细胞凋亡,当机体发生肿瘤时,肿瘤细胞表面Fas表达下调,有时甚至出现FasL的表达,不但削弱了阳性淋巴细胞的攻击能力,而且赋予了肿瘤细胞杀伤免疫细胞的能力,即肿瘤免疫逃逸。这一机制在皮肤肿瘤的发生发展中也有相当重要的作用。 Both Fas and FasL are cellular surface receptors,and Fas conjugated with FasL may induce cellular apeptosis. Sometimes skin cancer cellular Fas expression is depleted, even FasL appears on cellular surface,which not only decreaes attacking ability of positive lymphocytic eeUs, but also makes skin cancer cells killing immune cells,that is ca/led immune escape, whose mechanisms play an important role in skin cancer development.
作者 张瑞 王晓彦
出处 《医学综述》 2008年第7期1024-1026,共3页 Medical Recapitulate
关键词 FAS/FASL 皮肤肿瘤 免疫逃逸 Fas/FasL Skin cancer Immune escape
  • 相关文献

参考文献19

  • 1贺占青.Fas(Apo-1/CD95)及其配体与肿瘤诱导凋亡的研究现状[J].中国肿瘤临床与康复,2002,9(3):128-128. 被引量:3
  • 2赵艳,吴坤.死亡分子Fas/CD95与细胞凋亡[J].癌变.畸变.突变,2001,13(1):55-57. 被引量:6
  • 3Lee SH,Jang JJ,Lee JY,et al. Fas ligand is expressed in normal skin and in some cutaneous malignancies [ J ]. Br Dermatol, 1998, 139 (2) :186-191.
  • 4郭亚军,时玉舫.细胞学与肿瘤免疫学研究进展[M].第1版.北京:军事医学科学出版社,2000.10-23.
  • 5Dayan CM, Elsegood KA, Podack ER, et al. Fas ligand expression on epithelial cells [ J ]. Immunol Today, 1997,18 (5) :203-208.
  • 6Shiraki K, Tsuji N, Shloda T, et al. Expression of Fas llgand in liver metastases of human colon adenocarcinomas [ J ]. Proc Natl Acad Sci U S A, 1997,94(12) :6420-6425.
  • 7Niehans GA, Brunner T, Frizeller SP,et al. Human lung carcinoma express Fas ligand[ J]. Cancer Res, 1997,57(6) :1007-1012.
  • 8Ungefroren H, Voss M, Jansen M, et al. Human pancreatic adenocarcinomas express Fas and Fas ligand. Yet are resistant to Fas mediated apoptosis [ J ]. Cancer Res, 1998,58 (8) : 1741-1749.
  • 9郭梁,吴荣聪,王钊.与CD95相关的细胞凋亡和免疫调节[J].生命的化学,2002,22(2):106-110. 被引量:2
  • 10张博芬,张雪薇,肖莹,宋雨阳.Fas/FasL与消化道肿瘤的相关性[J].微生物学杂志,2003,23(4):56-58. 被引量:3

二级参考文献63

  • 1李宏军,俞莉章,郭应禄.Fas系统在肿瘤研究中的应用[J].中华外科杂志,1997,35(1):59-62. 被引量:30
  • 2Miyauchi-Hashimoto H, Okamoto H, Tanaka K, et al. Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A (XPA) model mice. J Invest Dermatol, 1999, 112:965 - 970.
  • 3Ando O, Suemoto Y, Kurimoto M, et al. Deficient Th1-type immune responses via impaired CD28 signaling in ultraviolet B-induced systemic immunosuppression and the restorative effect of IL - 12. J Dermatol Sci, 2000, 24:190 - 202.
  • 4van Steeg H, Kraemer KH. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today, 1999, 5:86 - 94.
  • 5Eveno E, Bourre F, Quilliet X,et al. Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. Cancer Res, 1995, 55:4325 -4332.
  • 6Filipowicz E, Adegboyega P, Sanchez RL, et al. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas. Cancer, 2002, 94:814-819.
  • 7Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers.Hum Mutat, 2003, 21:217 -228.
  • 8Jimbo T, Ichihashi M, Mishima Y, et al. Role of excision repair in UVB-induced depletion and recovery of human epidermal Langerhans cells. Arch Dermatol, 1992, 128:61 - 67.
  • 9Miyauchi-Hashimoto H, Tanaka K, Horio T. Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice. J Invest Dermatol, 1996, 107:343 - 348.
  • 10Rivas JM, Ullrich SE. The role of IL -4, IL - 10, and TNF - alpha in the immune suppression induced by ultraviolet radiation. J Leukoc Biol, 1994, 56:769 -775.

共引文献54

同被引文献42

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部